144 related articles for article (PubMed ID: 8453684)
1. Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.
Kusumoto T; Maehara Y; Emi Y; Sakaguchi Y; Baba H; Sakaguchi M; Sugimachi K
Cancer Chemother Pharmacol; 1993; 31(6):455-8. PubMed ID: 8453684
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia enhances the cytotoxicity against hypoxic cells of RP-170, a new 2-nitroimidazole nucleoside hypoxic cell sensitizer.
Emi Y; Maehara Y; Kusumoto T; Baba H; Sakaguchi M; Sugimachi K
Oncology; 1995; 52(1):55-9. PubMed ID: 7800343
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo radiosensitizing effects of 2-nitroimidazole derivatives with sugar component.
Murayama C; Tanaka N; Miyamoto Y; Sakaguchi M; Mori T
Strahlenther Onkol; 1987 Jun; 163(6):385-90. PubMed ID: 3603366
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radiosensitizing effect of the nitroimidazole derivative RK28 on the proliferation of MethA tumor cells in combined use with diethyldithiocarbamate.
Mashiba H; Matsunaga K; Hata K
Life Sci; 1991; 49(19):1419-25. PubMed ID: 1658511
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the radiosensitizing effects of RK28 intravenous, intraarterial, and intratumoral injections on the rabbit VX2 tumor system.
Ebe K; Suda H; Kuramitsu T; Honma Y; Nakanishi T; Miyata Y; Sakaguchi M; Matsunaga N
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1107-16. PubMed ID: 8985033
[TBL] [Abstract][Full Text] [Related]
6. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
[TBL] [Abstract][Full Text] [Related]
7. The potential of using hyperthermia to eliminate radioresistant hypoxic cells.
Overgaard J; Grau C; Lindegaard JC; Horsman MR
Radiother Oncol; 1991; 20 Suppl 1():113-6. PubMed ID: 2020761
[TBL] [Abstract][Full Text] [Related]
8. Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
Teicher BA; Herman TS; Holden SA; Rudolph MB
Cancer Lett; 1991 Aug; 59(2):109-17. PubMed ID: 1884367
[TBL] [Abstract][Full Text] [Related]
9. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
10. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
Twentyman PR
Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322
[TBL] [Abstract][Full Text] [Related]
11. Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.
Epelbaum R; Teicher BA; Holden SA; Ara G; Varshney A; Herman TS
Eur J Cancer; 1992; 28A(4-5):794-800. PubMed ID: 1524897
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
[TBL] [Abstract][Full Text] [Related]
13. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
Holden SA; Teicher BA; Herman TS
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
[TBL] [Abstract][Full Text] [Related]
14. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
Zhou L; Nishimoto S
Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of dual function nitrofurans in rodent and human tumor cells.
Siemann DW
Int J Radiat Oncol Biol Phys; 1992; 22(4):697-700. PubMed ID: 1544840
[TBL] [Abstract][Full Text] [Related]
16. Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.
Bleehen NM; Honess DJ; Morgan JE
Br J Cancer; 1977 Mar; 35(3):299-306. PubMed ID: 856237
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
Rockwell S
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1631-4. PubMed ID: 6434497
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
20. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells.
Teicher BA; Kowal CD; Kennedy KA; Sartorelli AC
Cancer Res; 1981 Mar; 41(3):1096-9. PubMed ID: 7459853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
